Xiao Z[au] - Search Results

Year	Number of Results
1979	1
1980	1
1981	2
1982	2
1983	4
1985	2
1986	7
1987	2
1988	13
1989	4
1990	7
1991	7
1992	10
1993	3
1994	7
1995	17
1996	12
1997	16
1998	18
1999	26
2000	21
2001	28
2002	40
2003	68
2004	90
2005	94
2006	101
2007	135
2008	172
2009	193
2010	211
2011	265
2012	278
2013	311
2014	347
2015	379
2016	378
2017	441
2018	502
2019	633
2020	708
2021	855
2022	1024
2023	298

1

Tumor Infiltrating Lymphocyte (TIL) Therapy for Solid Tumor Treatment: Progressions and Challenges.

Zhao Y, Deng J, Rao S, Guo S, Shen J, Du F, Wu X, Chen Y, Li M, Chen M, Li X, Li W, Gu L, Sun Y, Zhang Z, Wen Q, Xiao Z, Li J. Zhao Y, et al. Among authors: xiao z. Cancers (Basel). 2022 Aug 27;14(17):4160. doi: 10.3390/cancers14174160. Cancers (Basel). 2022. PMID: 36077696 Free PMC article. Review.

2

Monitoring Therapeutic Response to Anti-FAP CAR T Cells Using [18F]AlF-FAPI-74.

Lee IK, Noguera-Ortega E, Xiao Z, Todd L, Scholler J, Song D, Liousia M, Lohith K, Xu K, Edwards KJ, Farwell MD, June CH, Albelda SM, Puré E, Sellmyer MA. Lee IK, et al. Among authors: xiao z. Clin Cancer Res. 2022 Dec 15;28(24):5330-5342. doi: 10.1158/1078-0432.CCR-22-1379. Clin Cancer Res. 2022. PMID: 35972732

3

Comparison of the revised 4th (2016) and 5th (2022) editions of the World Health Organization classification of myelodysplastic neoplasms.

Zhang Y, Wu J, Qin T, Xu Z, Qu S, Pan L, Li B, Wang H, Zhang P, Yan X, Gong J, Gao Q, Gale RP, Xiao Z. Zhang Y, et al. Among authors: xiao z. Leukemia. 2022 Dec;36(12):2875-2882. doi: 10.1038/s41375-022-01718-7. Epub 2022 Oct 12. Leukemia. 2022. PMID: 36224330 Free PMC article.

4

Primate gastrulation and early organogenesis at single-cell resolution.

Zhai J, Guo J, Wan H, Qi L, Liu L, Xiao Z, Yan L, Schmitz DA, Xu Y, Yu D, Wu X, Zhao W, Yu K, Jiang X, Guo F, Wu J, Wang H. Zhai J, et al. Among authors: xiao z. Nature. 2022 Dec;612(7941):732-738. doi: 10.1038/s41586-022-05526-y. Epub 2022 Dec 14. Nature. 2022. PMID: 36517595 Free PMC article.

5

USP5-Beclin 1 axis overrides p53-dependent senescence and drives Kras-induced tumorigenicity.

Li J, Wang Y, Luo Y, Liu Y, Yi Y, Li J, Pan Y, Li W, You W, Hu Q, Zhao Z, Zhang Y, Cao Y, Zhang L, Yuan J, Xiao ZJ. Li J, et al. Among authors: xiao zj. Nat Commun. 2022 Dec 17;13(1):7799. doi: 10.1038/s41467-022-35557-y. Nat Commun. 2022. PMID: 36528652 Free PMC article.

6

The development and improvement of immunodeficient mice and humanized immune system mouse models.

Chen J, Liao S, Xiao Z, Pan Q, Wang X, Shen K, Wang S, Yang L, Guo F, Liu HF, Pan Q. Chen J, et al. Among authors: xiao z. Front Immunol. 2022 Oct 19;13:1007579. doi: 10.3389/fimmu.2022.1007579. eCollection 2022. Front Immunol. 2022. PMID: 36341323 Free PMC article. Review.

7

Assessment of cholesterol homeostasis in the living human brain.

Haider A, Zhao C, Wang L, Xiao Z, Rong J, Xia X, Chen Z, Pfister SK, Mast N, Yutuc E, Chen J, Li Y, Shao T, Warnock GI, Dawoud A, Connors TR, Oakley DH, Wei H, Wang J, Zheng Z, Xu H, Davenport AT, Daunais JB, Van RS, Shao Y, Wang Y, Zhang MR, Gebhard C, Pikuleva I, Levey AI, Griffiths WJ, Liang SH. Haider A, et al. Among authors: xiao z. Sci Transl Med. 2022 Oct 5;14(665):eadc9967. doi: 10.1126/scitranslmed.adc9967. Epub 2022 Oct 5. Sci Transl Med. 2022. PMID: 36197966

8

PROTACs in gastrointestinal cancers.

Chen Y, Yang Q, Xu J, Tang L, Zhang Y, Du F, Zhao Y, Wu X, Li M, Shen J, Ding R, Cao H, Li W, Li X, Chen M, Wu Z, Cho CH, Du Y, Wen Q, Xiao Z. Chen Y, et al. Among authors: xiao z. Mol Ther Oncolytics. 2022 Nov 3;27:204-223. doi: 10.1016/j.omto.2022.10.012. eCollection 2022 Dec 15. Mol Ther Oncolytics. 2022. PMID: 36420306 Free PMC article. Review.

9

Cuproptosis depicts tumor microenvironment phenotypes and predicts precision immunotherapy and prognosis in bladder carcinoma.

Li H, Zu X, Hu J, Xiao Z, Cai Z, Gao N, Chen J. Li H, et al. Among authors: xiao z. Front Immunol. 2022 Sep 23;13:964393. doi: 10.3389/fimmu.2022.964393. eCollection 2022. Front Immunol. 2022. PMID: 36211344 Free PMC article.

10

IPSS-M has greater survival predictive accuracy compared with IPSS-R in persons ≥ 60 years with myelodysplastic syndromes.

Wu J, Zhang Y, Qin T, Xu Z, Qu S, Pan L, Li B, Jia Y, Li C, Wang H, Gao Q, Cai W, Gong J, Zhao S, Li F, Gale RP, Xiao Z. Wu J, et al. Among authors: xiao z. Exp Hematol Oncol. 2022 Oct 17;11(1):73. doi: 10.1186/s40164-022-00328-4. Exp Hematol Oncol. 2022. PMID: 36253799 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results